medigraphic.com
ISSN 1561-2988 (Print)

2012, Number 2

<< Back Next >>

Rev Cubana Farm 2012; 46 (2)

Effects of D-002 on aspirin-induced ulcers and neutrophil infiltration on the gastric mucosa

Valle CM, Noa PM, Mendoza CS, Oyarzábal YA, Molina CV, Mendoza HN, Mas FR

Language: English
References: 38
Page: 249-258
PDF size: 150.13 Kb.


ABSTRACT

Introduction: the gastric mucosa is susceptible to the effects of aggressive factors, which are counterbalanced by mucosal defensive factors. Acid peptic diseases result from the imbalance between these aggressive and defensive factors. Aspirin-induced ulcer is a model of NSAIDs-induced damage in which neutrophil infiltration plays a key role.
Objective: this paper investigates the protective effect of D-002 against aspirin--induced ulcers and associated neutrophil infiltration in the gastric mucosa.
Methods: rats were randomized into six groups of 8 rats each. A negative vehicle control, and five aspirin (300 mg/kg)-treated groups: a positive control, orally treated with the vehicle, three with D-002 (25, 50 and 100 mg/kg, respectively) and other with 10 mg/kg Omeprazole. Five hours after induced damage the rats were sacrificed. The stomachs were removed and opened, and lesions examined macroscopically and microscopically. Ulcer indexes and neutrophil infiltration per ulcer areas were measured.
Results: all positive, none negative, controls exhibited aspirin-induced ulcers. Oral treatment with D-002 (25-100 mg/kg) dose-dependently and significantly reduced aspirin-induced gastric lesions (37 to 75 %), the mean number of microscopic ulcers (40 to 72 %) and neutrophil infiltration (41.7 to 83.1 %) in the rat gastric mucosa.
Conclusion: Oral treatment with D-002 (25-100 mg/kg) effectively protects against aspirin-induced ulcers and decreases the neutrophil infiltration in the gastric mucosa induced by aspirin ulceration.


REFERENCES

  1. Ramakrishnan K, Salinas RC. Peptic Ulcer Disease. Am Fam Physician. 2007;76:1005-12.

  2. Tasman-Jones C. Pathogenesis of peptic ulcer disease and gastritis: Importance of aggressive and cytoprotective factors. Scand J Gastroenterol. 1986;19(22):1-5.

  3. Lamarque D. Pathogenesis of gastroduodenal lesions induced by non-steroidal anti-inflammatory drugs. Gastroenterol Clin Biol. 2004;28:C18-26.

  4. Allen A, Flemström G. Gastroduodenal mucus bicarbonate barrier: protection against acid and pepsin. Am J Cell Physiol. 2005;288:C1-19.

  5. Laine L, Takeuchi K, Tarnawski A. Gastric mucosal defense and cytoprotection: bench to bedside. Gastroenterology. 2008;135:41-60.

  6. Wallace JL. Pathogenesis of NSAID-induced gastroduodenal mucosal injury. Best Pract Res Clin Gastroenterol. 2001;15:691703.

  7. Whittle BJ. Gastrointestinal effects of non-steroidal anti-inflammatory drugs. Fundam Clin Pharmacol. 2003;17:301-313.

  8. Komatsu Y, Nakamori Y, Kotani T, Takeuchi K. Pathogenic importance of cysteinyl leukotrienes in development of gastric lesions induced by ischemia/reperfusion in mice. Gastroenterology. 2009:134;A-240.

  9. Kountouras J, Chatzopoulos D, Zavos C. Reactive oxygen metabolites and upper gastrointestinal diseases. Hepatogastroenterology. 2001;48:743-51.

  10. Demir S, Yilmaz M, Koseoglu M, Akalin N, Aslan D, Aydin A. Role of free radicals in peptic ulcer and gastritis. Turkish J Gastroenterology. 2003;14:39-43.

  11. Yasukawa K, Kasazaki K, Hyodo F, Utsumi H. Non-invasive analysis of reactive oxygen species generated in rats with water immersion restraint-induced gastric lesions using in vivo electron spin resonance spectroscopy. Free Radic Res. 2004;38:147-55.

  12. Naito Y, Takagi T, Katada K, Tomatsuri N, Mizushima K, Handa O, et al. Gastric peroxisome proliferator activator receptor-ã expression and cytoprotective actions of its ligands against ischemia-reperfusion injury in rats. J Clin Biochem Nutr. 2011;48:170-7.

  13. Doweico HE. The Over-the-Counter Analgesics, Unexpected Agent of Abuse (Chapter eighteen) in Concept of chemical dependency. 7th ed. Belmont: Brooks/Cole Cengage Learning; 2009. p. 269.

  14. Pohle T, Brzozowski T, Becker JC, Van Der Voort IR. Role of reactive oxygen metabolites in aspirin-induced gastric damage in humans: gastroprotection by vitamin C. Aliment Pharmacol Ther. 2001;15:677-87.

  15. Sener-Muratoðlu G, Paskaloðlu K, Arbak S, Hürdað C, Ayanoðlu-Dülger G. Protective effect of famotidine, omeprazole, and melatonin against acetylsalicylic acid-induced gastric damage in rats. Dig Dis Sci. 2001;46:318-30.

  16. Jainu M, Devi S. Attenuation of neutrophil infiltration and proinflammatory cytokines by Cissus quadrangularis: a possible prevention against gastric ulcerogenesis. J Herb Pharmacother. 2005;5:33-42.

  17. Jainu M, Mohan V. Devi S. Protective effect of Cissus quadrangularis on neutrophil mediated tissue injury induced by aspirin in rats. J Ethnopharmacol. 2006:104;302-5.

  18. Carbajal D, Molina V, Valdés S, Arruzazabala L, Más R. Anti-ulcer activity of higher primary alcohols of beeswax. J Pharm Phamacol. 1995;47:731-3.

  19. Carbajal D, Molina V, Valdés S, Arruzazabala L, Rodeiro I, Más R, et al. Possible cytoprotective mechanism in rats of D-002 an anti-ulcerogenic product isolated from beeswax. J Pharm Pharmacol. 1996;48:858-60.

  20. Carbajal D, Molina V, Noa M, Valdes S, Arruzazabala ML, Aguiar A, et al. Effects of D-002 on gastric mucus composition in ethanol-induced ulcer. Pharmacol Res. 2000;42:329-32.

  21. Molina V, Valdés S, Carbajal D, Arruzazabala L, Menéndez R, Más R. Antioxidant effects of D-002 on gastric mucosa of rats with injury induced experimentally. J Med Food. 2001;4(2):79-84.

  22. Hano O, Illnait J, Mas R, Fernández L, Piñol F, Fernández JC. Effects of D-002, a Product Isolated from Beeswax, on Duodenal Ulcer: A Double-Blind, Placebo- Controlled Study. Curr Ther Res. 2001;62:394-407.

  23. Illnait J, Terry H, Mas R, Fernández L, Carbajal D. Effects of D-002, a product isolated from beeswax, on gastric symptoms of patients with osteoarthritis treated with piroxicam: a pilot study. J Med Food. 2005;8:63-8.

  24. Fernández L, Terry H, Quiñones AM, Díaz B, Hernández ML, Illnait J, et al. Effects of Abexol ® in middle-aged and older subjects: an open follow-up. Rev CENIC Cien Biol. 2008;39:3-8.

  25. Rodriguez I, Illnait J, Fernandez L, Terry H, Mas R, Fernández L, et al. Effects of Abexol® (beeswax alcohols) on gastrointestinal symptoms of middle-aged and older subjects assessed. Rev CENIC Cien Biol. 2009;40(3):147-54.

  26. Noa M, Más R, Carbajal D, Valdés S. Effect of D-002 on acetic acid-induced colitis in rats at single and repeated doses. Pharmacol Res. 2000;41:392-5.

  27. Noa M, Carbajal D, Molina V, Valdés S, Más R. Comparative study of D-002 vs sulfasalazine on acetic acid-induced colitis in rats. Drugs Exptl Clin Res. 1999;25:25-9.

  28. Angelo A, Hassan M, Nour El Din N, Khalifa HM, Ghany SA. A possible role for gastroprotectives on aspirin-induced gastric ulcer in rats. Alexandria J Med. 2010;46(1):75-82.

  29. Ko JK, Leung CC.J. Ginger extract and polaprezinc exert gastroprotective actions by anti-oxidant and growth factor modulating effects in rats. Gastroenterol Hepatol. 2010;25:1861-8.

  30. Nygard G, Amthony A, Piasecki C, Trevethick M, Hudson M, Dhilon A, et al. Acute indomethacin-induced jejunum injury in the rat. Early morphological and biochemical changes. Gastroenterology. 1994;106:567-75.

  31. Mukherjee M, Bhaskaran N, Srinath R, Shivaprasad HN, Allan JJ, Shekhar D, et al. Anti-ulcer and antioxidant activity of GutGard. Indian J Exp Biol. 2010;48:269-74.

  32. Ogawa K, Oyagi A, Tanaka J, Kobayashi S, Hara H. The Protective Effect and Action Mechanism of Vaccinium myrtillus L. on Gastric Ulcer in Mice. Phytother Res. 2011 Aug 25(8):1160-5.

  33. Sanmuganathan P. Ghahramani P. Jackson P. Ramsay L. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009;373:1849-60.

  34. Inzitari D, Piccardi B, Sarti C. A critical review of aspirin in the secondary prevention of non-cardioembolic ischaemic stroke. Int J Stroke. 2010;5:306-18.

  35. Tsumura H, Tamura I, Tanaka H, Chinzei R, , Masuda A, et al. Prescription of non-steroidal anti-inflammatory drugs and co-prescribed drugs for mucosal protection: analysis of the present status based on questionnaires obtained from orthopaedists in Japan. Inter Med. 2007;46:927-31.

  36. Berenguer B, Trabadela C, Sánchez-Fidalgo S, Quílez A, Miño P, De la Puerta R, et al. The aerial parts of Guazuma ulmifolia Lam. protect against NSAID-induced gastric lesions. Ethnopharmacol. 2007;114(2):153-60.

  37. Menéndez R, Amor AM, González RM, Jiménez S, Más R. Inhibition of rat microsomal lipid peroxidation by the oral administration of D-002. Braz J Med Biol Res. 2000;33:85-90.

  38. Carbajal D, Molina V, Valdés S, Arruzazabala ML, Más R, Magraner J. Antiinflammatory activity of D-002: an active product isolated from beeswax. Prostagl Leukotr Essent Fatty Acids. 1998;59(4):235-8.




2020     |     www.medigraphic.com